IL1B and chronic myelogenous leukemia, BCR-ABL1 positive: In CML, high levels of the cytokine IL-1β are associated with a worse prognosis and shorter survival times [77], and in CLL, IL-1β secretion can induce differentiation and activation of leukemic cells [78].